• 2645 Citations
  • 24 Scopus h-Index
20002019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Yanyan Lou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Neoplasms Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cancer Vaccines Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 2645 Citations
  • 24 Scopus h-Index
  • 38 Article
  • 3 Review article
  • 1 Editorial
5 Citations (Scopus)

Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy

Ye, Y., Hu, Q., Chen, H., Liang, K., Yuan, Y., Xiang, Y., Ruan, H., Zhang, Z., Song, A., Zhang, H., Liu, L., Diao, L., Lou, Y., Zhou, B., Wang, L., Zhou, S., Gao, J., Jonasch, E., Lin, S. H., Xia, Y. & 5 others, Lin, C., Yang, L., Mills, G. B., Liang, H. & Han, L., Apr 1 2019, In : Nature Metabolism. 1, 4, p. 431-444 14 p.

Research output: Contribution to journalArticle

Pharmaceutical Preparations
Drug Resistance
Therapeutics
Neoplasms
Atlases

Effects of age and immune landscape on outcome in HER2-positive breast cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) trials

Chumsri, S., Serie, D. J., Li, Z., Pogue-Geile, K. L., Soyano-Muller, A. E., Mashadi-Hossein, A., Warren, S., Lou, Y., Colon-Otero, G., Knutson, K. L., Perez, E. A., Moreno Aspitia, A. & Thompson, E. A., Jan 1 2019, In : Clinical Cancer Research. 25, 14, p. 4422-4430 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
adjuvant P40
B 31
Trastuzumab

Hypereosinophilia in a patient with metastatic non-small-cell lung cancer treated with antiprogrammed cell death 1 (anti-PD-1) therapy

Lou, Y., Marin-Acevedo, J. A., Vishnu, P., Manochakian, R., Dholaria, B., Soyano, A., Luo, Y., Zhang, Y. & Knutson, K. L., May 1 2019, In : Immunotherapy. 11, 7, p. 577-584 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Eosinophilia
Cell Death
Therapeutics
Eosinophils

Influence of Sociodemographic Factors on Treatment Decisions in Non–Small-Cell Lung Cancer

Duma, N., Idossa, D. W., Durani, U., Frank, R. D., Paludo, J., Westin, G., Lou, Y., Mansfield, A. S., Adjei, A. A., Go, R. S. & Ailawadhi, S., Jan 1 2019, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Treatment Refusal
Drug Therapy
Therapeutics
Radiotherapy
2 Citations (Scopus)

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

Duma, N., Abdel-Ghani, A., Yadav, S., Hoversten, K. P., Reed, C. T., Sitek, A. N., Enninga, E. A. L., Paludo, J., Aguilera, J. V., Leventakos, K., Lou, Y., Kottschade, L. A., Dong, H. M., Mansfield, A., Manochakian, R., Adjei, A. & Dronca, R. S., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Programmed Cell Death 1 Receptor
Non-Small Cell Lung Carcinoma
Sex Characteristics
Melanoma
Therapeutics